Drug Discoveries & Therapeutics, cilt.7, sa.5, ss.196-200, 2013 (Scopus)
ABSTRACT: The aim of this study was to test for a
potential anticarcinogenic effect of Celergen, a marine
derivative devoid of traceable amounts of inorganic
arsenic, on cell proliferation, cell cycle progression
and apoptosis in the HepG2 human liver cancer cell
line. Celergen significantly inhibited the proliferation
of cancer cells in a dose-dependent manner while
limiting the cell cycle progression at the G1 phase and
significantly inducing apoptosis. Further examination
showed that Celergen enhanced expression of the
p21CIPl1WAF1, GADD153 genes and downregulated the
c-myc gene. These results suggest that Celergen exerts
promising chemopreventive properties to be further
investigated.